Skip to Main Content

Providers: Summary of Formulary Changes Effective Jan. 1, 2021

Date: 01/16/21

Fort Lauderdale, Florida

The Florida Medicaid Pharmaceutical and Therapeutics Committee meets quarterly and gives recommendations to the Agency for Health Care Administration (AHCA) for updates to the Medicaid Preferred Drug List (PDL). Sunshine Health wants to ensure that our providers have the most up-to-date information.
The following changes were made at the Dec. 11, 2020, Florida Medicaid Pharmaceutical and Therapeutics Committee meeting and are effective beginning Jan. 1, 2021. Sunshine Health currently uses the AHCA PDL.

Added Medications

  • AMBRISENTAN (ORAL)~
  • AMITIZA (ORAL)*
  •  ANORO ELLIPTA (INHALATION)
  • DELZICOL (ORAL)
  • ENBREL VIAL (SUBCUTANEOUS)*
  • ESZOPICLONE (ORAL)
  • HUMALOG JUNIOR KWIKPEN (SUBCUTANEOUS)
  • KESIMPTA (SUBCUTANEOUS)
  • LIALDA (ORAL)
  •  OLOPATADINE DROPS AG (PATADAY) (OPHTHALMIC)
  • OLOPATADINE DROPS (PATADAY) (OPHTHALMIC)
  • SYMLIN PENS (SUBCUTANEOUS)
  • SYNTHROID (ORAL)
  • TRI-VITAMIN W/FLUORIDE (ORAL)
  • TRULICITY (SUBCUTANEOUS)
  • VENTOLIN HFA (INHALATION)

Removed Medications

  • BEVESPI AEROSPHERE (INHALATION)
  • FIRVANQ (ORAL)
  • HEMATOGEN FA CAPSULE (ORAL)
  • HUMULIN PEN OTC (SUBCUTANEOUS)
  • LETAIRIS (ORAL)
  • MESALAMINE DR 400 MG (ORAL)
  • MOXIFLOXACIN (OPHTHALMIC)
  • PANTOPRAZOLE SUSPENSION (ORAL)
  • PROVENTIL HFA (INHALATION)
  • THYROLAR (ORAL)
  • UTIBRON NEOHALER (INHALATION)
  • VANALICE GEL OTC (TOPICAL)
  • VANCOMYCIN IN 5% DEXTROSE (INTRAVENOUS)

*   Auto PA

~  Clinical PA